References
- Becker B., Hahn K. Topical CortIcosterolds and heredity In primary open-angle glaucoma. Am. J. Ophthalmol. 1964; 57: 543–551
- Becker B. The genetic problem of chronic simple glaucoma. Ann. Ophthalmol. 1971; 3: 351–354
- Becker B. Intraocular pressure response to topical cortIcosterolds. Invest. Ophthalmol. 1965; 4: 198–205
- Armaly M. Statistical attributes of the steroid hypertensive response in the clinically normal eye: I. The demonstration of three levels of response. Invest. Ophthalmol. 1965; 4: 187–197
- Armaly M. Dexamethasone ocular hypertension In the clinically normal eye. II. The untreated eye, outflow facility, and concentration. Arch. Ophthalmol. 1966; 75: 776–782
- Cantrill H., Palmberg P., Zink H., Waltman S., Podos S., Becker B. Comparison of In vitro potency of cortI costerolds with ability to raise Intraocular pressure. Am. J. Ophthalmol. 1975; 79: 1012–1017
- Kitazawa Y. Increased intraocular pressure induced by corticosterolds, Am. J. Ophthalmol. 1976; 82: 492–495
- Stewart R., Kimbrough R. Intraocular pressure response to topically administered fluorometholone. Arch. Ophthalmol. 1979; 97: 2139–2140
- Mindel J., Tavitian H., Smith H., Walker E. Comparative ocular pressure elevation by medrysone, fIuorometholone and dexamethasone phosphate. Arch. Ophthalmol. 1980; 98: 1577–1578
- Kupferman A., Pratt M., Suckewer K., Leibowitz H. Topically applied steroids In corneal disease: III. The role of drug derivative in stromal absorption of dexamethasone. Arch. Ophthalmol. 1974; 91: 373–376
- Leibowitz H., Kupferman A. Bio-aval lability and therapeutic effectiveness of topically administered cortlcosteroids. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1975; 79: 78–88
- Kupferman A., Leibowitz H. Topically applied steroids in corneal disease: V. Dexamethasone alcohol. Arch. Ophthalmol. 1975; 92: 329–330
- Welnreb R., Mitchell M., Polansky J. Prostagland In production by human trabecular cells: In vitro inhibition by dexamethasone. Invest. Ophthalmol. Vis. Sci. 1983; 24/12: 1541–1545
- Falrbairn W., Thorson J. Fluoro-metholone anti-inflammatory and intraocular pressure effects. Arch. Ophthalmol. 1971; 86: 138–141
- Buch H., Ellis R. Clinical studies with a new steroid-fluorocnethol one. Ann. Ophthalmol. 1975; 7: 937–939
- Kupferman A., Berrospi A., Leibowitz H. Fluorometholone acetate: A new ophthalmic derivative of fluorometholone. Arch. Ophthalmol. 1982; 100: 640–641
- Lelbowftz H., Hyndluk R., Lindsey C., Smith J., Rosenthal A. A clinical comparison of fIuorometholone acetate, fIuorometholone and prednisolone acetate in the treatment of external ocular inflammation. Ann. Ophthalmol. 1984, Submitted for publication
- Mindel J., Goldberg J., Tavltian H. Similarity of the intraocular pressure response to different cortlcosteroid esters when compliance is controlled. Ophthalmol., AAO 1979; 86: 98–108